“Beyond PD-1 PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance”. Journal of Biomolecules, Pathogenesis and Therapeutics, vol. 2, no. 1, Mar. 2026, https://jbptjournal.org/index.php/jbpt/article/view/33.